» Articles » PMID: 34714469

Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders

Overview
Journal Mol Neurobiol
Date 2021 Oct 29
PMID 34714469
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are multipotent, adult stem cells which are found in numerous tissues like the umbilical cord, Wharton's jelly, bone marrow, and adipose tissue. They possess the capacity of self-renewal by dividing and differentiating into various cellular lineages. Their characteristic therapeutic potential exploited so far has made them a desirable candidate in regenerative medicine. Neurodegenerative diseases (NDs) like Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and ischemic stroke have been treated with MSCs and MSC-derived products. Over the past few decades, we have witnessed significant contributions in discovering the etiology of various NDs and their possible therapeutic solutions. One of the MSC-based therapeutics is extracellular vesicles (EVs), which contain multiple biologically active molecules like nucleic acids and proteins. The contents of EVs are ferried between cells for intercellular communication which then leads to regulation of the homeostasis of recipient cells. EVs serve as a considerable means of cell-free therapies like for tissue repair or regeneration as EVs can maintain therapeutically effective cargo of parent cells and are free of various ethical issues in cell-based therapies. Due to paucity of standard protocols in extraction procedures of EVs and their pharmacological properties and mechanisms, the development of new EV dependent therapies is challenging. With this review, an attempt has been made to annotate these mechanisms, which can help advance the novel therapeutic approaches towards the treat and define a more narrowed down approach for each ND to devise effective MSC-based therapies to cure and avert these diseases.

Citing Articles

The Role of Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Modulating Dermal Fibroblast Activity: A Pathway to Enhanced Tissue Regeneration.

Barathan M, Ham K, Wong H, Law J Biology (Basel). 2025; 14(2).

PMID: 40001918 PMC: 11852171. DOI: 10.3390/biology14020150.


Brown Adipose Tissue undergoes pathological perturbations and shapes C2C12 myoblast homeostasis in the SOD1-G93A mouse model of Amyotrophic Lateral Sclerosis.

Rosina M, Scaricamazza S, Riggio F, Fenili G, Giannessi F, Matteocci A Heliyon. 2025; 11(3):e41801.

PMID: 39916853 PMC: 11800085. DOI: 10.1016/j.heliyon.2025.e41801.


Intranasal delivery of small extracellular vesicles reduces the progress of amyotrophic lateral sclerosis and the overactivation of complement-coagulation cascade and NF-ĸB signaling in SOD1 mice.

Zhou J, Li F, Jia B, Wu Z, Huang Z, He M J Nanobiotechnology. 2024; 22(1):503.

PMID: 39174972 PMC: 11340036. DOI: 10.1186/s12951-024-02764-2.


Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles.

Liu X, Shen L, Wan M, Xie H, Wang Z J Nanobiotechnology. 2024; 22(1):170.

PMID: 38610012 PMC: 11015679. DOI: 10.1186/s12951-024-02428-1.


Therapeutic advances in neural regeneration for Huntington's disease.

DEgidio F, Castelli V, Lombardozzi G, Ammannito F, Cimini A, dAngelo M Neural Regen Res. 2024; 19(9):1991-1997.

PMID: 38227527 PMC: 11040295. DOI: 10.4103/1673-5374.390969.


References
1.
FRIEDENSTEIN A, Chailakhyan R, Latsinik N, Panasyuk A . Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974; 17(4):331-40. DOI: 10.1097/00007890-197404000-00001. View

2.
Ferreira J, Teixeira G, Santos S, Barbosa M, Almeida-Porada G, Goncalves R . Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning. Front Immunol. 2018; 9:2837. PMC: 6288292. DOI: 10.3389/fimmu.2018.02837. View

3.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

4.
Raposo G, Stoorvogel W . Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200(4):373-83. PMC: 3575529. DOI: 10.1083/jcb.201211138. View

5.
Felicetti F, De Feo A, Coscia C, Puglisi R, Pedini F, Pasquini L . Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med. 2016; 14:56. PMC: 4765208. DOI: 10.1186/s12967-016-0811-2. View